ACR Convergence 2025

October 24-29, 2025. Chicago, Illinois.

View by Number View by Title View Sessions

Abstract Number: 0178

Prevalence and factors associated with virtual rheumatology care utilization in a national population of Veterans with RA
Abstract Number: 0179

Digital Divide in Rheumatology: Patterns of Technology and AI Adoption Across Generations of Specialists
Abstract Number: 0180

Digital Transformation in IMID Care: Results from the Implementation of IMIDOC
Abstract Number: 0181

Launch of the National Tele-Rheumatology Program (NTRP) to Expand Rheumatology Care to Rural Veterans
Abstract Number: 0182

A Joint Effort: Implementing Depression Screening in a Safety-Net Rheumatology Clinic
Abstract Number: 0183

Optimizing the Clinical Application of Rheumatology Guidelines Using Large Language Models: A Retrieval-Augmented Generation Framework Integrating EULAR and ACR Recommendations
Abstract Number: 0184

Neurocognitive Complications of Lupus: A Multidisciplinary Program Model for Advanced Diagnostics, Management, and Clinical Research
Abstract Number: 0185

Promoting Health Services Research Rigor and Reproducibility using CodeMapper: A novel tool for harmonization, collaboration, and precision
Abstract Number: 0186

Validation of Asynchronous Telehealth Visit for Adults and Children with Inflammatory Arthritis and Feasibility of Applying Thermal Imaging during Visits
Abstract Number: 0187

Message Testing in Online Recruitment Advertisements for a National Rheumatoid and Psoriatic Arthritis Study
Abstract Number: 0188

Investigating Canadians’ information needs related to lupus: A Google Trends analysis of online search query data
Abstract Number: 0189

“Try it, you’ll love it”: Patterns of AI Scribes Use Among Rheumatologists
Abstract Number: 0190

Health literacy and comorbidity burden: a cluster analysis in a national cohort of people with inflammatory arthritis
Abstract Number: 0191

Advanced therapy use in RA patients with moderate disease activity in a large NHS Foundation Trust in South London, UK
Abstract Number: 0192

Digital Empowerment on Hold: Adoption Gaps in Prescribable Digital Health Applications – A National Cross-Sectional Study from Germany

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].